FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799547478> ?p ?o ?g. }

• W2799547478 abstract "Older patients with cancer suffer from chemotherapy-related toxicities more frequently than younger patients. As novel agents are being used more commonly in chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL), toxicities of these agents in older patients have not been well studied. Further, impact of these toxicities on outcomes in the elderly is unknown. This study aimed to answer both questions.We reviewed 14 Alliance for Clinical Trials in Oncology trials that enrolled CLL and/or NHL patients between 2004-2014. Toxicity was assessed per the NCI-CTCAE (version 3-5). Probabilities of experiencing grade three or four hematologic and non-hematologic toxicities were modeled as a function of clinical and disease-related factors using logistic regression.1199 patients (409 age ≥ 65; 790 age < 65) were analyzed; 438 received only biologic therapy (145 age ≥ 65; 293 age < 65), and 761 received biologic + chemotherapy (264 age ≥ 65; 497 age < 65). The odds of grade three or four hematologic [odds ratio (OR) 1.70; p = 0.009: 95% CI (1.57-1.84)] and non-hematologic toxicities [OR 1.47; p = 0.022; 95% CI (1.39-1.55)] were increased in older patients with CLL, as well as odds of grade three or four non-hematologic toxicities [OR 1.89; p = 0.017; 95% CI (1.64-2.17)] in older patients with NHL. Grade three or four hematologic toxicities were associated with inferior OS and PFS in older patients with NHL [HR 3.14; p = 0.006; 95% CI (2.25-4.39) for OS and 3.06; p = 0.011; 95% CI (2.10-4.45) for PFS], though not in CLL. A prognostic model predicting grade three or four toxicities was also developed.CLL and NHL patients ≥ 65 year encounter more toxicities than younger patients even when treated with novel biologic agents. Development of grade three or four hematologic toxicities lead to inferior PFS and OS in NHL but not in CLL." @default.
• W2799547478 created "2018-05-17" @default.
• W2799547478 creator A5000921376 @default.
• W2799547478 creator A5005446802 @default.
• W2799547478 creator A5007726590 @default.
• W2799547478 creator A5009044758 @default.
• W2799547478 creator A5031116230 @default.
• W2799547478 creator A5032861872 @default.
• W2799547478 creator A5032903376 @default.
• W2799547478 creator A5037882455 @default.
• W2799547478 creator A5041339246 @default.
• W2799547478 creator A5045054591 @default.
• W2799547478 creator A5050334795 @default.
• W2799547478 creator A5056567340 @default.
• W2799547478 creator A5059012052 @default.
• W2799547478 creator A5063699585 @default.
• W2799547478 date "2018-07-01" @default.
• W2799547478 modified "2023-10-16" @default.
• W2799547478 title "Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)" @default.
• W2799547478 cites W116524609 @default.
• W2799547478 cites W1499155424 @default.
• W2799547478 cites W1933587402 @default.
• W2799547478 cites W1994709165 @default.
• W2799547478 cites W1996904182 @default.
• W2799547478 cites W1998451121 @default.
• W2799547478 cites W2006713638 @default.
• W2799547478 cites W2018317078 @default.
• W2799547478 cites W2028378614 @default.
• W2799547478 cites W2032685816 @default.
• W2799547478 cites W2035811581 @default.
• W2799547478 cites W2038793941 @default.
• W2799547478 cites W2054965659 @default.
• W2799547478 cites W2071813692 @default.
• W2799547478 cites W2072351874 @default.
• W2799547478 cites W2076668534 @default.
• W2799547478 cites W2077180817 @default.
• W2799547478 cites W2082276392 @default.
• W2799547478 cites W2104755629 @default.
• W2799547478 cites W2119173914 @default.
• W2799547478 cites W2126856198 @default.
• W2799547478 cites W2141681661 @default.
• W2799547478 cites W2145770938 @default.
• W2799547478 cites W2151595445 @default.
• W2799547478 cites W2153294383 @default.
• W2799547478 cites W2157215276 @default.
• W2799547478 cites W2192832798 @default.
• W2799547478 cites W2331849216 @default.
• W2799547478 cites W2512116734 @default.
• W2799547478 cites W2549586432 @default.
• W2799547478 cites W4237434210 @default.
• W2799547478 cites W4300571226 @default.
• W2799547478 doi "https://doi.org/10.1016/j.jgo.2018.03.018" @default.
• W2799547478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6015785" @default.
• W2799547478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29673807" @default.
• W2799547478 hasPublicationYear "2018" @default.
• W2799547478 type Work @default.
• W2799547478 sameAs 2799547478 @default.
• W2799547478 citedByCount "3" @default.
• W2799547478 countsByYear W27995474782019 @default.
• W2799547478 countsByYear W27995474782020 @default.
• W2799547478 crossrefType "journal-article" @default.
• W2799547478 hasAuthorship W2799547478A5000921376 @default.
• W2799547478 hasAuthorship W2799547478A5005446802 @default.
• W2799547478 hasAuthorship W2799547478A5007726590 @default.
• W2799547478 hasAuthorship W2799547478A5009044758 @default.
• W2799547478 hasAuthorship W2799547478A5031116230 @default.
• W2799547478 hasAuthorship W2799547478A5032861872 @default.
• W2799547478 hasAuthorship W2799547478A5032903376 @default.
• W2799547478 hasAuthorship W2799547478A5037882455 @default.
• W2799547478 hasAuthorship W2799547478A5041339246 @default.
• W2799547478 hasAuthorship W2799547478A5045054591 @default.
• W2799547478 hasAuthorship W2799547478A5050334795 @default.
• W2799547478 hasAuthorship W2799547478A5056567340 @default.
• W2799547478 hasAuthorship W2799547478A5059012052 @default.
• W2799547478 hasAuthorship W2799547478A5063699585 @default.
• W2799547478 hasBestOaLocation W27995474782 @default.
• W2799547478 hasConcept C121608353 @default.
• W2799547478 hasConcept C126322002 @default.
• W2799547478 hasConcept C143998085 @default.
• W2799547478 hasConcept C151956035 @default.
• W2799547478 hasConcept C156957248 @default.
• W2799547478 hasConcept C194409129 @default.
• W2799547478 hasConcept C2776694085 @default.
• W2799547478 hasConcept C2777938653 @default.
• W2799547478 hasConcept C2778461978 @default.
• W2799547478 hasConcept C2779338263 @default.
• W2799547478 hasConcept C535046627 @default.
• W2799547478 hasConcept C71924100 @default.
• W2799547478 hasConceptScore W2799547478C121608353 @default.
• W2799547478 hasConceptScore W2799547478C126322002 @default.
• W2799547478 hasConceptScore W2799547478C143998085 @default.
• W2799547478 hasConceptScore W2799547478C151956035 @default.
• W2799547478 hasConceptScore W2799547478C156957248 @default.
• W2799547478 hasConceptScore W2799547478C194409129 @default.
• W2799547478 hasConceptScore W2799547478C2776694085 @default.
• W2799547478 hasConceptScore W2799547478C2777938653 @default.
• W2799547478 hasConceptScore W2799547478C2778461978 @default.
• W2799547478 hasConceptScore W2799547478C2779338263 @default.
• W2799547478 hasConceptScore W2799547478C535046627 @default.
• W2799547478 hasConceptScore W2799547478C71924100 @default.

• next